Loading stock data…
$41.21-0.46 (-1.10%)
Molson Coors Beverage Company manufactures, markets, distributes, and sells beer and other malt beverage products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Molson Coors Beverage Company in the Consumer Defensive sector is trading at $41.21 with a market capitalization of $7.3B. Wall Street consensus targets $43.67 (21 analysts), implying a +6.0% move over the next 12 months. The stock is currently 25% below its 52-week high of $54.82, remaining 1.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 76 is overbought against a weak tape. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.10B↑ | $2.35B↓ | $2.66B↓ | $2.97B↓ | $3.20B |
| Gross Profit | $1.06B↑ | $897.20M↓ | $968.30M↓ | $1.17B↓ | $1.28B |
| Operating Income | $344.80M↑ | $287.20M↓ | $357.40M↓ | $486.80M↓ | $588.80M |
| Net Income | $231.70M↑ | $151.30M↓ | $238.30M↑ | -$2.93B↓ | $428.70M |
Molson Coors Beverage Company manufactures, markets, distributes, and sells beer and other malt beverage products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers flavored malt beverages including hard seltzers, craft...
Academic risk and quality models computed from TAP's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, below the current 30.9% reading.
Fama-French 5-factor market beta. The five factors explain 28% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-23.